Global menu

Our global pages

Close
 
Claudia Teo, Partner

Claudia Teo

Partner

Practice areas

  • Capital market law
  • Commercial agreements
  • Corporate
  • Cryptoassets
  • Financial services and markets regulation
  • Investment funds and asset management
  • Mergers and acquisitions
  • Private equity

Practice notes

Claudia is Head of the Corporate and Financial Services Practice Group in Singapore. Her main areas of practice are in corporate finance and M&A transactions throughout Asia. She has over 20 years’ experience in corporate and securities laws, advising on cross-border, transactions in addition to initial public offerings on the Singapore Stock Exchange.  Some of her complex deal structures have focused on various industries including healthcare and pharmaceuticals, fintech, natural resources, lifestyle and real estate and construction.   She also has extensive experience in investment funds, collective investment schemes and related regulatory and licensing requirements.

Before joining the Firm, Claudia practiced with a local law firm and an international law firm in Singapore. Prior to that, she lived and worked abroad for 12 years in both London and Hong Kong, advising on initial public offerings and compliance issues on the Hong Kong Stock Exchange.

Claudia was recommended in the 2016 edition of The Legal 500 as well as in the 2014 edition of Asialaw’s Leading Publication and was described by Asia Pacific Legal 500 as having as “flexible, walk-the-extra-mile approach” and “always goes the extra mile”.  One of her clients described her team as “very intelligent and incisive lawyers, absolutely focused on helping [us] achieve our objectives" in Asialaw Profiles 2016.  Her Practice Group was awarded various accolades by leading legal publications and has been ranked in the Bloomberg Global Legal Adviser League Tables and most recently in the Bloomberg Global Mergers & Acquisitions Review Table for South East Asian deals for Q1 2017.

Claudia has been appointed as a director of Ren Ci Hospital & Medicare Centre, a Singapore charity healthcare institution, since 2018 and is also a member of the investment/governance & risk committee since 2013. She is also an independent director of iX Biopharma Ltd, an innovative late-stage specialty pharmaceutical company with expertise in drug delivery and formulation. Claudia was called to the Singapore Bar and is dually qualified as a barrister and a solicitor of England and Wales and is admitted to the Rolls of Solicitors of Hong Kong.